Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1117-2019Class I

Edwards Lifesciences, Miller Balloon Atrioseptostomy Catheter, Sterile EO, Rx Only, REF: 830515F

Edwards Lifesciences LLC / initiated 2019-03-28 / Terminated / root cause: manufacturing process

Edwards Lifesciences, LLC began a recall of Edwards Lifesciences, Miller Balloon Atrioseptostomy Catheter, Sterile EO, Rx Only, REF: 830515F Product Usage: The Miller balloon atrioseptostomy catheter is... on . FDA classified it as Class I and gives the reason as "Difficulty with atrioseptostomy catheter balloon deflation after deployment, and reports of balloon fragmentation or detachment". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1117-2019
Classification
Class I
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Edwards Lifesciences LLC
Product
Edwards Lifesciences, Miller Balloon Atrioseptostomy Catheter, Sterile EO, Rx Only, REF: 830515F Product Usage: The Miller balloon atrioseptostomy catheter is designed for enlarging interatrial openings. In most pediatric cardiology centers, balloon atrioseptostomy is an accepted technique for palliation of several congenital cardiac defects. Description of Use Balloon atrioseptostomy can be performed in conjunction with diagnostic cardiac catheterization or under echocardiographic guidance and has been carried out after the diagnosis of several congenital cardiac defects including but not limited to: transposition of the great arteries, total anomalous pulmonary venous drainage without pulmonary obstruction, tricuspid atresia, and pulmonary atresia with intact ventricular septum.
Product code
DXF Catheter, Septostomy
Reason for recall
Difficulty with atrioseptostomy catheter balloon deflation after deployment, and reports of balloon fragmentation or detachment.
Root cause tag
manufacturing process
FDA root cause
Process design
Action
On 03/28/19, Urgent Product Recall - Action Required Field Corrective Action notices were mailed FedEx Second Day to customers. The letter identified the affected product problem and actions to be taken. The firm is requesting the return of any existing inventory of these models. They are conducting an investigation of the issues. At this time, they do not have an estimated date as to when replacement product will become available. The firm urges customers to inquire as to the availability of similar products. Customers with additional questions are encouraged to call 800-424-3278 Option 1. Firm requests that customers fill out and return Customer Acknowledgement forms within 10 days of receipt of this notification.
Quantity in commerce
1564
Distribution
Worldwide Distribution - US Nationwide in the states of : IA, FL, MD, CA, NY, TX, CT, NC, OR, LA, UT,AK, WA, AZ, SD,CO,IN, KY, WV, TN, MI, AL, MA, VA, PA, MO, IL, GA, PR, MN, AR, OK, WI. Foreign (OUS): CL, AR, CZ, SG, BR, ID, ES, IE, GB, AT, CA, AM, HK, AU, ZA, FI, KR, MY, TH, NL, FR, IT, GR, DK, SE, DE, TR, QA, NZ, SA, PS, PT, JP, CH, IL, AE, BE, EE
Product codes and lots
All lots within 15 months expiry from 03/01/2019

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1117-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1116-2019Class ITerminatedVoluntary: Firm initiated
Z-1117-2019Class ITerminatedVoluntary: Firm initiated